| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.15 | 0.4 |